Current Smoking Does Not Modify the Treatment Effect of Intravenous Thrombolysis in Acute Ischemic Stroke Patients—A Post-hoc Analysis of the WAKE-UP Trial
Ludwig Schlemm(Humboldt-Universität zu Berlin), Matthias Endres(German Center for Neurodegenerative Diseases), Götz Thomalla(Universität Hamburg), Ian Ford, Robin Lemmens(VIB-KU Leuven Center for Microbiology), Salvador Pedraza(Hospital Clínic de Barcelona), Alexander H. Nave(Universität Hamburg), Keith W. Muir(University of Glasgow), Norbert Nighoghossian(Université Claude Bernard Lyon 1), Anna Kufner(Humboldt-Universität zu Berlin), Martin Ebinger(Universität Hamburg), Christian Gerloff(Universität Hamburg), Claus Z. Simonsen(Universität Hamburg), Florent Boutitie(Université Claude Bernard Lyon 1)
Cited by 11
Related Papers
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|809